Related Content
Search Google Scholar for:
|
|
Science 20 July 1990: Vol. 249. no. 4966, pp. 293 - 295 DOI: 10.1126/science.2115690
|
|
Articles
Science, Vol 249, Issue 4966, 293-295
Copyright © 1990 by American Association for the Advancement of Science
MHC-linked protection from diabetes dissociated from clonal deletion of T cells
J Bohme,
B Schuhbaur,
O Kanagawa,
C Benoist,
and
D Mathis
Laboratoire de Genetique Moleculaire des Eucaryotes du CNRS, Faculte de Medecine, Strasbourg, France.
The I-E molecule of the major histocompatibility complex (MHC) can prevent the spontaneous development of diabetes in nonobese diabetic (NOD) mice. The mechanism of this protection has been investigated by breeding wild-type and promoter-mutated E kappa alpha transgenes onto the NOD genetic background. Animals carrying the various mutated transgenes expressed I-E on different subsets of immunocompetent cells, and thus cells important for the I-E protective effect could be identified. Although the wild-type transgene prevented the infiltration of lymphocytes into pancreatic islets, none of the mutants did. However, all of the transgenes could mediate the intrathymic elimination of T cells bearing antigen receptors with variable regions that recognize I-E. Thus, the I-E molecule does not protect NOD mice from diabetes simply by inducing the deletion of self-reactive T cells.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.
- A. M. D'Alise, V. Auyeung, M. Feuerer, J. Nishio, J. Fontenot, C. Benoist, and D. Mathis (2008)
PNAS
105, 19857-19862
| Abstract »
| Full Text »
| PDF »
- Protection of Murine Systemic Lupus by the Ea Transgene without Expression of I-E Heterodimers.
- E. Martinez-Soria, M.-L. Santiago-Raber, L. Ho, T. Moll, and S. Izui (2008)
J. Immunol.
181, 3651-3657
| Abstract »
| Full Text »
| PDF »
- PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice.
- T. Yoshida, F. Jiang, T. Honjo, and T. Okazaki (2008)
PNAS
105, 3533-3538
| Abstract »
| Full Text »
| PDF »
- Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.
- M. Feuerer, W. Jiang, P. D. Holler, A. Satpathy, C. Campbell, M. Bogue, D. Mathis, and C. Benoist (2007)
PNAS
104, 18181-18186
| Abstract »
| Full Text »
| PDF »
- Restricted MHC-peptide repertoire predisposes to autoimmunity.
- N. N. Logunova, C. Viret, L. A. Pobezinsky, S. A. Miller, D. B. Kazansky, J. P. Sundberg, and A. V. Chervonsky (2005)
J. Exp. Med.
202, 73-84
| Abstract »
| Full Text »
| PDF »
- NOD B-cells Are Insufficient to Incite T-Cell-Mediated Anti-islet Autoimmunity.
- D. J. Moore, H. Noorchashm, T. H. Lin, S. A. Greeley, and A. Naji (2005)
Diabetes
54, 2019-2025
| Abstract »
| Full Text »
| PDF »
- Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination.
- D. Zhang, K. Fujio, Y. Jiang, J. Zhao, N. Tada, K. Sudo, H. Tsurui, K. Nakamura, K. Yamamoto, H. Nishimura, et al. (2004)
PNAS
101, 13838-13843
| Abstract »
| Full Text »
| PDF »
- Imaging inflammation of the pancreatic islets in type 1 diabetes.
- M. C. Denis, U. Mahmood, C. Benoist, D. Mathis, and R. Weissleder (2004)
PNAS
101, 12634-12639
| Abstract »
| Full Text »
| PDF »
- In a Transgenic Model of Spontaneous Autoimmune Diabetes, Expression of a Protective Class II MHC Molecule Results in Thymic Deletion of Diabetogenic CD8+ T Cells.
- D. J. Morgan, C. T. Nugent, B. J. E. Raveney, and L. A. Sherman (2004)
J. Immunol.
172, 1000-1008
| Abstract »
| Full Text »
| PDF »
- Ex Vivo Analysis of Thymic CD4 T Cells in Nonobese Diabetic Mice with Tetramers Generated from I-Ag7/Class II-Associated Invariant Chain Peptide Precursors.
- M.-H. Jang, N. P. Seth, and K. W. Wucherpfennig (2003)
J. Immunol.
171, 4175-4186
| Abstract »
| Full Text »
| PDF »
- Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones.
- K. Yoshida, T. Martin, K. Yamamoto, C. Dobbs, C. Munz, N. Kamikawaji, N. Nakano, H.-G. Rammensee, T. Sasazuki, K. Haskins, et al. (2002)
Int. Immunol.
14, 1439-1447
| Abstract »
| Full Text »
| PDF »
- T-Cell Tolerance by Dendritic Cells and Macrophages as a Mechanism for the Major Histocompatibility Complex-Linked Resistance to Autoimmune Diabetes.
- S. Thiessen, P. Serra, A. Amrani, J. Verdaguer, and P. Santamaria (2002)
Diabetes
51, 325-338
| Abstract »
| Full Text »
| PDF »
- IL-12 Administration Reveals Diabetogenic T Cells in Genetically Resistant I-E{alpha}-Transgenic Nonobese Diabetic Mice: Resistance to Autoimmune Diabetes Is Associated with Binding of E{alpha}-Derived Peptides to the I-Ag7 Molecule.
- S. Trembleau, S. Gregori, G. Penna, I. Gorny, and L. Adorini (2001)
J. Immunol.
167, 4104-4114
| Abstract »
| Full Text »
| PDF »
- Expression of a Tolerizing Tumor Antigen in Peripheral Tissue Does Not Preclude Recovery of High-Affinity CD8+ T Cells or CTL Immunotherapy of Tumors Expressing the Antigen.
- C. Ohlen, M. Kalos, D. J. Hong, A. C. Shur, and P. D. Greenberg (2001)
J. Immunol.
166, 2863-2870
| Abstract »
| Full Text »
| PDF »
- Protection from Radiation-Induced Colitis Requires MHC Class II Antigen Expression by Cells of Hemopoietic Origin.
- S. Marguerat, H. R. MacDonald, J.-P. Kraehenbuhl, and J. P. M. van Meerwijk (1999)
J. Immunol.
163, 4033-4040
| Abstract »
| Full Text »
| PDF »
- A Peptide Binding Motif for I-Eg7, the MHC Class II Molecule That Protects E{alpha}-Transgenic Nonobese Diabetic Mice from Autoimmune Diabetes.
- S. Gregori, S. Trembleau, G. Penna, F. Gallazzi, J. Hammer, G. K. Papadopoulos, and L. Adorini (1999)
J. Immunol.
162, 6630-6640
| Abstract »
| Full Text »
| PDF »
- Sequence Analysis of the Diabetes-Protective Human Leukocyte Antigen-DQB10602 Allele in Unaffected, Islet Cell Antibody-Positive First Degree Relatives and in Rare Patients with Type 1 Diabetes.
- A. Pugliese, E. Kawasaki, M. Zeller, L. Yu, S. Babu, M. Solimena, C. T. Moraes, M. Pietropaolo, R. P. Friday, M. Trucco, et al. (1999)
J. Clin. Endocrinol. Metab.
84, 1722-1728
| Abstract »
| Full Text »
- Contributions of Eaz and Ebz MHC Genes to Lupus Susceptibility in New Zealand Mice.
- T. J. Vyse, S. J. Rozzo, C. G. Drake, V. B. Appel, M. Lemeur, S. Izui, E. Palmer, and B. L. Kotzin (1998)
J. Immunol.
160, 2757-2766
| Abstract »
| Full Text »
| PDF »
- Major Histocompatibility Complex Class II Molecules Can Protect from Diabetes by Positively Selecting T Cells with Additional Specificities.
- F. Luhder, J. Katz, C. Benoist, and D. Mathis (1998)
J. Exp. Med.
187, 379-387
| Abstract »
| Full Text »
| PDF »
- Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes.
- F. Luhder, P. Hoglund, J. P. Allison, C. Benoist, and D. Mathis (1998)
J. Exp. Med.
187, 427-432
| Abstract »
| Full Text »
| PDF »
- Major Histocompatibility Complex-linked Control of Autoimmunity.
- L. S. Wicker (1997)
J. Exp. Med.
186, 973-975
| Full Text »
| PDF »
- A Mechanism for the Major Histocompatibility Complex-linked Resistance to Autoimmunity.
- D. Schmidt, J. Verdaguer, N. Averill, and P. Santamaria (1997)
J. Exp. Med.
186, 1059-1075
| Abstract »
| Full Text »
| PDF »
- Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors.
- M. Lipes, A Rosenzweig, K. Tan, G Tanigawa, D Ladd, J. Seidman, and G. Eisenbarth (1993)
Science
259, 1165-1169
| Abstract »
| PDF »
- Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells.
- F. Luhder, C. Chambers, J. P. Allison, C. Benoist, and D. Mathis (2000)
PNAS
97, 12204-12209
| Abstract »
| Full Text »
| PDF »
|
|